Holen Sie sich die Stockscreener-App
72.34
4.18%
-3.005
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$75.35
Offen:
$72.34
24-Stunden-Volumen:
836.97K
Relative Volume:
0.37
Marktkapitalisierung:
$34.91B
Einnahmen:
$10.63B
Nettoeinkommen (Verlust:
$819.00M
KGV:
43.64
EPS:
1.6577
Netto-Cashflow:
$1.59B
1W Leistung:
+2.31%
1M Leistung:
+6.47%
6M Leistung:
-8.09%
1J Leistung:
-16.08%
1-Tages-Spanne:
$72.11
$72.77
1-Wochen-Bereich:
$69.17
$76.20
52-Wochen-Spanne:
$61.84
$90.41
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
72.22 | 36.42B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
398.70 | 141.75B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
178.60 | 49.41B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.47 | 32.61B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.94 | 30.74B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Alcon’s New-Product Wave Carries Q2 As It Walks Away From Accommodating IOL Bet - insights.citeline.com
Alcon stock slips as profit reset follows stronger Q2 growth - AD HOC NEWS
Mizuho raises Alcon stock price target to $85 on new products - Investing.com Canada
Key facts: Alcon AG (ALC) Q2 sales +7%; Q3 gross margin to rise - TradingView
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments - VisionMonday.com
Alcon Inc (ALC) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Strategic Pivots ... - Yahoo Finance Singapore
ALC Maintains Buy Rating by Needham -- Price Target Raises to $9 - GuruFocus
New Launches and Pipeline Investments Support Alcon's Market Leadership and Strong Fundamentals - Morningstar
How Is Alcon (NYSE:ALC) Tracking on the NYSE Composite Today? - Kalkine Media
Swiss Market Index Blinks Red; Alcon Shares Rise - marketscreener.com
BTIG reiterates Buy on Alcon stock after Q2 results beat margins - Investing.com
AlphaValue sees clear skies ahead for Alcon - marketscreener.com
Alcon Stock Jumps 4% as Tariff Relief Lifts Profit Target - GuruFocus
AlphaValue says the outlook is clear for Alcon - marketscreener.com
Alcon Q2 2026 slides: 7% growth, margin gains despite PowerVision hit - Investing.com
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs - TradingView
Alcon : Second-Quarter 2026 Earnings Call Regulatory Filing - marketscreener.com
Alcon Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Alcon Inc. (ALC) Q2 FY2026 earnings call transcript - Yahoo Finance
Alcon raises 2026 earnings growth outlook on positive Q2 results - Yahoo Finance
Alcon Lifts 2026 Outlook Amid Higher First-half Sales, Lower Tariff Impact Forecast - marketscreener.com
Alcon Raises 2026 Profit Guidance as Expected U.S. Refund Reduces Tariff Impact - Yahoo Finance
Alcon rises on profit guidance hike, lowered tariff impact estimate By Investing.com - Investing.com Canada
Alcon Jumps 5.7% After Tariff Refund Drives Up 2026 Profit Forecast - TechStock²
Eye care company Alcon raises margin outlook, shares jump - TradingView
Alcon Inc. (ALC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Eye care company Alcon raises profitability outlook, cuts tariff hit estimate - 1470 & 100.3 WMBD
Alcon raises its 2026 profit targets - marketscreener.com
Alcon (SWX:ALC), Why Is Its Latest Update Drawing Attention? - Yahoo Finance
Alcon Posts Lower H1 Attributable Net Income; Net Sales Grow - marketscreener.com
Alcon (ALC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Why is Alcon stock surging today? By Investing.com - Investing.com Canada
Alcon rises ahead of earnings as investors bet on product momentum - Quiver Quantitative
Alcon Inc. (ALC) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Alcon shares leap 5% on better-than-expected Q2 results By Investing.com - Investing.com South Africa
Alcon lifts 2026 outlook after Q2 adjusted EPS beat estimates - TradingView
Earnings Flash (ALC) Alcon Inc. Reports Q2 Revenue $2.78B, vs. FactSet Est of $2.76B - marketscreener.com
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth - Business Wire
Alcon earnings up next: Can revenue growth ease margin pressure? - Investing.com
Alcon Inc. (ALC) Stock Analysis: Tapping into a 21.6% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
Alcon to Use Google(x) Smart Lens Technology | Business | Aug 2014 - Photonics Spectra
Is It Too Late to Buy Alcon Inc (ALC) After 3.3% Rally? GF Value Says Undervalued - GuruFocus
Alcon AG expected to post earnings of 76 cents a shareEarnings Preview - TradingView
Prévisions Alcon: croissance organique légèrement supérieure attendue - TradingView
STAAR Surgical appoints Warren Foust as permanent CEO - MedTech Dive
RXST: Entered a $60M+ collaboration with Alcon as product sales declined and leadership transitioned - TradingView
RxSight (NASDAQ: RXST) reports $33.7M Q2 revenue and $60M Alcon collaboration - Stock Titan
Alcon (ALC) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo! Finance Canada
Alcon Inc. (ALC) Stock Analysis: 26.66% Potential Upside In Healthcare Giant - DirectorsTalk Interviews
Do Options Traders Know Something About Alcon Stock We Don't? - TradingView
Alcon stock trades steadily as surgical vision business underpins earnings growth - Ad-hoc-news.de
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):